Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 4/2004

01-08-2004 | Original paper

Protective effect of aminoguanidine against nephrotoxicity induced by amikacin in rats

Authors: H. Parlakpinar, M. Koc, A. Polat, N. Vardi, M. K. Ozer, Y. Turkoz, A. Acet

Published in: Urolithiasis | Issue 4/2004

Login to get access

Abstract

Aminoglycoside antibiotics have long been used in antibacterial therapy. Despite their beneficial effects, aminoglycosides have considerable nephrotoxic and ototoxic side effects. It has been reported that reactive oxygen radical species (ROS) play role in the pathophysiology of aminoglycosides-induced nephrotoxicity. Aminoguanidine (AG) is an effective antioxidant and free radical scavenger which has long been known to protect against nephrotoxicity. We investigated the effects of AG on amikacin (AK)-induced changes of renal malondialdehyde (MDA), glutathione (GSH), blood urea nitrogen (BUN), serum creatinine (Cr) and albumin (Alb) which are used to monitor the development of renal tubular damage. Morphological changes in the kidney were also examined using light microscopy. A total of 21 rats were equally divided into three groups which were: (1) injected with saline, (2) injected with AK, and (3) injected with AK+AG, respectively. AK administration to control rats increased renal MDA and decreased GSH levels. AG administration before AK injection caused significant decreases in MDA and increases in GSH levels in kidneys compared to rats treated with AK alone. The serum BUN level increased slightly, Cr and serum Alb did not change as a result of any treatment. AG tended to decrease the level of serum BUN and did not cause any change in Alb or Cr levels. Morphological changes, including glomerular, tubular epithelial alterations and interstitial edema, were clearly observed in AK-treated rats. In addition, AG reversed the morphological damage to the kidney induced by AK. The results show that AG has a protective effect on nephrotoxicity induced by AK and may therefore improve the therapeutic index of AK.
Literature
1.
Begg EJ, Barclay ML (1995) Aminoglycosides-50 years on. Br J Clin Pharmacol 39: 597PubMed
2.
Klein J, Koren G, McLeod SM (1992) Comparison methods for prediction of nephrotoxicity during development. Dev Pharmacol Ther 19: 80PubMed
3.
Ibrahim S, Langhendries JP, Bernard A, Tulkens PM (1994) Urinary phospholipids excretion in neonates treated with amikacin. Int J Clin Pharmacol Res 14: 149PubMed
4.
Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV (1998) In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53: 394CrossRefPubMed
5.
Rao M, Kumar MM, Rao MA (1999) In vitro and in vivo effects of phenolic antioxidants against cisplatin-induced nephrotoxicity. J Biochem 125: 383PubMed
6.
Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233: 119CrossRefPubMed
7.
Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML (1993) Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation endproduct formation. Diabetes 42: 221PubMed
8.
Sugimoto K, Yagihashi S (1997) Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats. Microvasc Res 53: 105CrossRefPubMed
9.
Ihm SH, Yoo HJ, Park SW, Ihm J (1999) Effect of aminoguanidine on lipid peroxidation in streptozotocin induced diabetic rats. Metabolism 48: 1141PubMed
10.
Szabo C, Ferrer-Sueta G, Zingarelli B, Southan GJ, Salzman AL, Radi R (1997) Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 272: 9030CrossRefPubMed
11.
Aoki K, Ohmori M, Takimoto M, Ota H, Yoshida T (1997) Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species. Eur J Pharmacol 336: 43CrossRefPubMed
12.
Shiomi M, Wakabayashi Y, Sano T, Sinoda Y, Nimura Y, Ishimura Y, Suematsu M (1998) Nitric oxide suppression reversibly attenuates mitochondrial dysfunction and cholestasis in endotoxemic rat liver. Hepatology 27: 108PubMed
13.
Al-Shabanah OA, Alam KS, Nagi MN, Al-Rikabi AC, Al-Bekairi AM (2000) Protective effect of aminoguanidine, a nitric oxide synthase inhibitor, against carbon tetrachloride induced hepatotoxicity in mice. Life Sci 66: 265CrossRefPubMed
14.
Mansour MA, Mostafa AM, Nagi MN, Khattab MM, Al-Shabnah OA (2002) Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats. Comp Biochem Physiol C 132: 123CrossRef
15.
Parlakpinar H, Ozer MK, Sahna E, Vardi N, Cigremis Y, Acet A (2003) Amikacin-induced acute renal injury in rats protective role of melatonin. J Pineal Res 35: 85CrossRefPubMed
16.
Takizawa S, Fukuyama N, Hirabayashi H, Nakazawa H, Shinohara Y (1999) Dynamics of nitrotyrosine formation and decay in rat brain during focal ischemia-reperfusion J Cereb Blood Flow Metab 19: 667
17.
Vermeulen NPE, Baldew GS (1992) The role of lipid peroxidation in the nephrotoxicity of cisplatin. Biochem Pharmacol 44: 1193CrossRefPubMed
18.
Sahna E, Parlakpinar H, Ozturk F, Cigremis Y, Acet A (2003) The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res 31: 188CrossRefPubMed
19.
20.
Moore RD, Lietman PS, Smith C (1987). Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155: 93PubMed
21.
Prins JM, Weverling GJ, De Blok K, Van Ketel RJ, Speelman P (1996) Validation and nephrotoxicity of a simplified once-daily aminoglycoside schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 40: 2494PubMed
22.
Smith CR, Lipsky JJ, Laskin OL, Hellman DB, Mellits ED, Longstreth J, Lietman PS (1980) Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 302: 1106PubMed
23.
Gilbert DN (1995) Aminoglycosides. Principles and practice of infectious diseases, 4th edn. Churchill Livingstone, New York, p 279
24.
Hagiwara M, Inagaki M, Kanamura K, Ohta H, Hidaka H (1988) Inhibitory effects of aminoglycosides on renal protein phosphorylation by protein kinase C. J Pharmacol Exp Ther 244: 355PubMed
25.
Halliwell B, Gutteridge JMC, Cross CE (1992) Free radicals, antioxidants and human disease. Where are we now? J Lab Clin Med 119: 598PubMed
26.
Wolff SP (1993) Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stressing the etiology of diabetes mellitus and complications. Br Med Bull 49: 642PubMed
27.
Yildiz G, Demiryurek AT, Sahin-Erdemli I, Kanzik I (1998) Comparison of antioxidant activities of aminoguanidine, methyl-guanidine and guanidine by luminol-enhanced chemiluminescence. Br J Pharmacol 124: 905PubMed
28.
Giardino I, Fard AK, Hatchell DL, Brownlee M (1998) Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 47: 1114PubMed
29.
Babu E, Gopalakrishnan VK, Sriganth IN, Gopalakrishnan R, Sakthisekaran D (1995) Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem 144: 7PubMed
30.
Parlakpinar H, Sahna E, Ozer MK, Ozugurlu F, Vardi N, Acet A (2002) Physiological and pharmacological concentrations of melatonin protect against cisplatin induced acute renal injury. J Pineal Res 33: 161CrossRefPubMed
31.
Sugimoto H, Shikata K, Wada J, Horiuchi S, Makino H (1999) Advanced glycation end products–cytokine–nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumor necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 42: 878CrossRefPubMed
Metadata
Title
Protective effect of aminoguanidine against nephrotoxicity induced by amikacin in rats
Authors
H. Parlakpinar
M. Koc
A. Polat
N. Vardi
M. K. Ozer
Y. Turkoz
A. Acet
Publication date
01-08-2004
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 4/2004
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-004-0399-5

Other articles of this Issue 4/2004

Urolithiasis 4/2004 Go to the issue

Book Review

Udal Patel, David Rickards: Handbook of transrectal ultrasound and biopsy of the prostate

Invited Editorial

The genetic make-up of renal cell tumors

Original Paper

Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria

Original Paper

Induction of anoikis by doxazosin in prostate cancer cells is associated with activation of caspase-3 and a reduction of focal adhesion kinase

Original Paper

The presence of microscopic hematuria detected by urine dipstick test in the evaluation of patients with renal colic

Original Paper

Bladder augmentation with an omental pedicled gastric seromuscular flap without the necessity of gastric resection